loadpatents
name:-0.19826292991638
name:-0.016746997833252
name:-0.0015039443969727
Louie-Helm; Jenny Patent Filings

Louie-Helm; Jenny

Patent Applications and Registrations

Patent applications and USPTO patent grants for Louie-Helm; Jenny.The latest application filed is for "dual drug dosage forms with improved separation of drugs".

Company Profile
0.16.22
  • Louie-Helm; Jenny - Fremont CA US
  • Louie-Helm; Jenny - Union City CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
Grant 9,980,903 - Berner , et al. May 29, 2
2018-05-29
Dual Drug Dosage Forms With Improved Separation Of Drugs
App 20170202817 - Lim; Jong ;   et al.
2017-07-20
Shell-and-core Dosage Form Approaching Zero-order Drug Release
App 20170172930 - Berner; Bret ;   et al.
2017-06-22
Shell-and-core dosage form approaching zero-order drug release
Grant 9,597,338 - Berner , et al. March 21, 2
2017-03-21
Dual drug dosage forms with improved separation of drugs
Grant 9,572,780 - Lim , et al. February 21, 2
2017-02-21
Dual Drug Dosage Forms With Improved Separation Of Drugs
App 20160030352 - Lim; Jong ;   et al.
2016-02-04
Shell-and-core Dosage Form Approaching Zero-order Drug Release
App 20150182541 - Berner; Bret ;   et al.
2015-07-02
Dual drug dosage forms with improved separation of drugs
Grant 8,999,388 - Lim , et al. April 7, 2
2015-04-07
Shell-and-core dosage form approaching zero-order drug release
Grant 8,945,619 - Berner , et al. February 3, 2
2015-02-03
Dual Drug Dosage Forms With Improved Separation Of Drugs
App 20140186515 - Lim; Jong ;   et al.
2014-07-03
Dual drug dosage forms with improved separation of drugs
Grant 8,685,450 - Lim , et al. April 1, 2
2014-04-01
Shell-and-core Dosage Form Approaching Zero-order Drug Release
App 20130164377 - Berner; Bret ;   et al.
2013-06-27
Gastric Retentive Oral Dosage Form With Restricted Drug Release In The Lower Gastrointestinal Tract
App 20130149379 - Berner; Bret ;   et al.
2013-06-13
Shell and core dosage form approaching zero-order drug release
Grant 8,329,215 - Berner , et al. December 11, 2
2012-12-11
Dual Drug Dosage Forms With Improved Separation Of Drugs
App 20120263792 - LIM; JONG ;   et al.
2012-10-18
Gastric Retentive Oral Dosage Form With Restricted Drug Release In The Lower Gastrointestinal Tract
App 20110301129 - BERNER; BRET ;   et al.
2011-12-08
Shell-and-core dosage form approaching zero-order drug release
Grant 8,043,630 - Berner , et al. October 25, 2
2011-10-25
Shell And Core Dosage Form Approaching Zero-order Drug Release
App 20110236485 - BERNER; BRET ;   et al.
2011-09-29
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
Grant 7,976,870 - Berner , et al. July 12, 2
2011-07-12
Shell-and-Core Dosage Form Approaching Zero-Order Drug Release
App 20100272808 - Berner; Bret ;   et al.
2010-10-28
Shell-and-core dosage form approaching zero-order drug release
Grant 7,736,667 - Berner , et al. June 15, 2
2010-06-15
Dual drug dosage forms with improved separation of drugs
App 20050013863 - Lim, Jong ;   et al.
2005-01-20
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
App 20040185105 - Berner, Bret ;   et al.
2004-09-23
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
App 20040156899 - Louie-Helm, Jenny ;   et al.
2004-08-12
Extending the duration of drug release within the stomach during the fed mode
Grant 6,635,280 - Shell , et al. October 21, 2
2003-10-21
Formulation of an erodible, gastric retentive oral diuretic
App 20030152622 - Louie-Helm, Jenny ;   et al.
2003-08-14
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
App 20030133985 - Louie-Helm, Jenny ;   et al.
2003-07-17
Shell-and-core dosage form approaching zero-order drug release
App 20030104062 - Berner, Bret ;   et al.
2003-06-05
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
App 20030104052 - Berner, Bret ;   et al.
2003-06-05
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
App 20030091630 - Louie-Helm, Jenny ;   et al.
2003-05-15
Extending the duration of drug release within the stomach during the fed mode
App 20030039688 - Shell, John W. ;   et al.
2003-02-27
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
Grant 6,488,962 - Berner , et al. December 3, 2
2002-12-03
Extending the duration of drug release within the stomach during the fed mode
App 20020051820 - Shell, John W. ;   et al.
2002-05-02
Extending the duration of drug release within the stomach during the fed mode
Grant 6,340,475 - Shell , et al. January 22, 2
2002-01-22
Extending The Duration Of Drug Release Within The Stomach During The Fed Mode
App 20010018070 - SHELL, JOHN W. ;   et al.
2001-08-30
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
Grant 5,972,389 - Shell , et al. October 26, 1
1999-10-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed